Biogen Inc. (BIIB) vs ResMed Inc. (RMD)
RMD leads on 9 of 15 compared metrics.
A side-by-side comparison of Biogen Inc. and ResMed Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 25, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
Total return — BIIB vs RMD
growth of $100 · last 30yBIIB +5056.4%RMD +19760.0%RMD compounded faster
BIIB RMD
BIIB vs RMD: by the numbers
- •BIIB is the larger company ($29.82B vs $28.81B market cap).
- •RMD trades at the lower earnings multiple (19.21 vs 21.62 P/E).
- •RMD converts more revenue to profit (27.44% vs 13.92% net margin).
- •RMD grew revenue faster over the past five years (12.37% vs -4.80% CAGR).
- •RMD pays a dividend (1.21% yield) while BIIB does not currently pay one.
Which is better, BIIB or RMD?
Metric tally: BIIB 6 · RMD 9It depends on what you're optimizing for:
ValueRMD(lower P/E)
GrowthRMD(faster 5Y revenue CAGR)
QualityRMD(higher ROIC)
Metrics side by side
Valuation
| Metric | BIIB | RMD |
|---|---|---|
| P/E ratio | 21.62 | 19.21● |
| Forward P/E | 12.37● | 16.22 |
| P/S ratio | 3.04● | 5.27 |
| P/B ratio | 1.61● | 4.50 |
| PEG ratio | — | 0.72 |
| EV / EBITDA | 12.27● | 12.99 |
| FCF yield | 8.75%● | 5.99% |
Profitability
| Metric | BIIB | RMD |
|---|---|---|
| Gross margin | 69.77%● | 61.69% |
| Operating margin | 15.65% | 34.28%● |
| Net margin | 13.92% | 27.44%● |
| ROE | 7.36% | 23.41%● |
| ROIC | 6.62% | 19.56%● |
Dividends
| Metric | BIIB | RMD |
|---|---|---|
| Dividend yield | — | 1.21% |
| Payout ratio | — | 25.13% |
Growth (annualized)
| Metric | BIIB | RMD |
|---|---|---|
| Revenue CAGR (5Y) | -4.80% | 12.37%● |
| EPS CAGR (5Y) | -18.67% | 17.25%● |
| FCF CAGR (5Y) | -3.59% | 18.98%● |
| Total return CAGR (5Y) | -10.31% | -3.22%● |
Frequently asked
- Which is better, BIIB or RMD?
- It depends on your goal. value: RMD (lower P/E); growth: RMD (faster 5Y revenue CAGR); quality: RMD (higher ROIC). Across all compared metrics, RMD leads 9 to 6.
- Is BIIB or RMD cheaper?
- On trailing earnings, RMD is cheaper: BIIB trades at a 21.62 P/E and RMD at 19.21.
- Which has grown faster, BIIB or RMD?
- Over the past five years, RMD grew revenue faster — BIIB at a -4.80% CAGR versus RMD at 12.37%.
- Does BIIB or RMD pay a bigger dividend?
- RMD pays a dividend (1.21% yield) while BIIB does not currently pay one.
- Is BIIB or RMD more profitable?
- RMD runs the higher net margin — BIIB at 13.92% versus RMD at 27.44%.
- Which has been the better investment, BIIB or RMD?
- Over the past 10-year, RMD delivered the higher annualized total return — BIIB at -1.25% versus RMD at 13.90%. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Biogen P/E ratioResMed P/E ratioBiogen dividend yieldResMed dividend yieldBiogen ROEResMed ROEBiogen operating marginResMed operating marginBiogen revenue growthResMed revenue growthBiogen free cash flowResMed free cash flow
Biogen & ResMed appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 25, 2026.